Companies · Other Health Care

ASC Laurelhurst LLC

BELLEVUE · Other Health Care

Diligence memoA one-page analyst read on ASC Laurelhurst LLC — recommendation, valuation, rhythm, risks.
$50.4M
Total raised · real
2
Rounds
4.3×
Latest step-up
Top 9%
Sector rank · raised
Series C
Latest stage · inferred · Fri Jun 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

ASC Laurelhurst LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.64× the median modeled value of Series C Other Health Care companies in 2019–2021 (46 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

ASC Laurelhurst LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
9.0 yr record
Peak capital year was 2021 with $40.9M across 1 filings.
Market position
ahead of 92% of Other Health Care peers
Capital scale is ahead of 92% of Other Health Care peers; modeled value is above 95% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2021: $40.9M across 1 filings.
  • Largest single filing was $40.9M on 2021-06-04.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

ASC Laurelhurst LLC is one of 5377 Other Health Care companies tracked from BELLEVUE. By capital raised it ranks among the largest (ahead of 92% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
116
Investors (latest)
2016
Year incorporated
2021-06-04
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2017-06-28 Raised $9.6M (real) Modeled valuation $193M (est)$9.6M$193MSeries A2017Series C · 2021-06-04 Raised $41M (real) Modeled valuation $737M (est)$41M$737MSeries C2021+$41MCumulative $50M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$9.6M · 2017
Series C$40.9M · 2021no Series B on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$736.7M
Base estimate est.
$148.5M
Conservative case
$1.7B
Upside case
$272.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $192.7M · 2017-06-282017Series C · modeled $736.7M · 2021-06-042021
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
5.1 yr
Elapsed time used
5.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
47 mo
Avg between rounds
$12.8M/yr
Capital velocity
9.0 yr
On record since
2017
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 21× above median
This company$50.4M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.9× of median
This company$40.9M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 33× above median
This company$736.7M
Sector median$22.1M

Raised more than 92% of sector peers (real $). Modeled value above 95% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #38 of 46.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Avail Medsystems, Inc. · Series C Raised $126.7M · modeled $2.2B (est)Whoop, Inc. · Series C Raised $180.4M · modeled $2.1B (est)HRGi Holdings, Inc. · Series C Raised $91.2M · modeled $2.1B (est)Ambulnz, Inc. · Series C Raised $90.0M · modeled $2.1B (est)MedAvail, Inc. · Series C Raised $97.0M · modeled $2.0B (est)SOC Telemed, Inc. · Series C Raised $103.0M · modeled $1.9B (est)Eargo, Inc. · Series C Raised $187.4M · modeled $1.9B (est)Truth Holdings, L.P. · Series C Raised $88.8M · modeled $1.6B (est)NeuroPace Inc · Series C Raised $208.6M · modeled $1.5B (est)DermTech, Inc. · Series C Raised $98.9M · modeled $1.5B (est)Mydna, Inc · Series C Raised $72.1M · modeled $1.4B (est)Ancora Heart, Inc. · Series C Raised $151.3M · modeled $1.4B (est)ASC Laurelhurst LLC (this company) Raised $50.4M · modeled $736.7M (est)ASC Laurelhurst LLC
CompanyStageRaised · realValue · estvs peer med.
Avail Medsystems, Inc.Series C$126.7M$2.2B1.87×
Whoop, Inc.Series C$180.4M$2.1B1.81×
HRGi Holdings, Inc.Series C$91.2M$2.1B1.81×
Ambulnz, Inc.Series C$90.0M$2.1B1.79×
MedAvail, Inc.Series C$97.0M$2.0B1.75×
SOC Telemed, Inc.Series C$103.0M$1.9B1.65×
Eargo, Inc.Series C$187.4M$1.9B1.61×
Truth Holdings, L.P.Series C$88.8M$1.6B1.43×
NeuroPace IncSeries C$208.6M$1.5B1.33×
DermTech, Inc.Series C$98.9M$1.5B1.29×
Mydna, IncSeries C$72.1M$1.4B1.26×
Ancora Heart, Inc.Series C$151.3M$1.4B1.24×
ASC Laurelhurst LLC this companySeries C$50.4M$736.7M0.64×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$9.6M2017-06-28$43.4M$192.7M90%
Series C$40.9M2021-06-04$272.4M$736.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$9.6M2017-06-28
    • First recorded raise — entered as Series A.
    • 20 investors on this round.
  2. Series C$40.9M2021-06-04
    • Raised again after 47 mo — slower than the ~14 mo sector norm.
    • Round 4.3× larger than the prior — scaling up.
    • 116 investors on this round.
Intelligence
2025 ~Q2
Modeled next raise · ~47mo cadence
$122.6M
Modeled next size est.range $79.7M$196.2M
4.3×
Last step-up
$12.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Dwayne J. Clark12 other2017-06
Jerry C. Meyer11 other2017-06
Richard J. Tait7 other2017-06
Edward J. Poplawski6 other2017-06
Adam J. Clark5 other2021-06
Ashley J. Rea5 other2021-06
Registry & provenance

ASC Laurelhurst LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1710851
SEC CIK
2016
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Asc Overlake LlcOther Health CareSeries B$20.2M$448.1Mnetwork4 shared operators · same sector
ASC Ballard LLCOther Health CareSeries B$19.6M$271.6Mnetwork4 shared operators · same sector
Asc Kirkland LlcOther Health CareSeries B$19.2M$425.0Mnetwork4 shared operators · same sector
ASC Carkeek Park LLCOther Health CareSeries B$16.9M$374.4Mnetwork4 shared operators · same sector
ASC Lake Hills LLCOther Health CareSeries A$6.9M$79.9Mnetwork4 shared operators · same sector
ASC Admiral Way LLCOther Health CareSeries A$4.1M$83.5Mnetwork4 shared operators · same sector
ASC Ravenna LLCOther Health CareSeed$3.6M$90.5Mnetwork4 shared operators · same sector
ASC Mercer Island LLCOther Health CareSeed$1.9M$47.7Mnetwork4 shared operators · same sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Brentwood ASC, LLCOther Health CareSeed$60.7M88%
Livingston Asc, LlcOther Health CareSeed$22.7M87%
ASC Lake Hills LLCOther Health CareSeries A$79.9M86%
ASC San Rafael LLCOther Health CareSeries B$295.1M86%
ASC Ballard LLCOther Health CareSeries B$271.6M86%
Lutheran Campus ASC, LLCOther Health CarePre-Seed$1.5M86%
Greater New Haven ASC, LLCOther Health CarePre-Seed$590K86%
Asc Kirkland LlcOther Health CareSeries B$425.0M85%
Frequently asked
How much funding has ASC Laurelhurst LLC raised?
ASC Laurelhurst LLC has raised approximately $50.4M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is ASC Laurelhurst LLC's estimated valuation?
Provath's modeled valuation for ASC Laurelhurst LLC is approximately $736.7M (modeled range $148.5M–$1.7B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is ASC Laurelhurst LLC at?
ASC Laurelhurst LLC's latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Jun 04.
What does ASC Laurelhurst LLC do and where is it based?
ASC Laurelhurst LLC operates in the Other Health Care sector, based in BELLEVUE.
Explore related

See where ASC Laurelhurst LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at ASC Laurelhurst LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.